Share this via
Sun Pharmaceutical Industries on Thursday reported a 20% year-on-year decline in consolidated net profit to ₹2,279 crore for the first quarter ended June 30, 2025
Earlier, the U.S. President had announced plans to impose a 25% tariff on India, along with an additional penalty, citing concerns over the country's energy and defence ties with Russia, as well as existing trade barriers
Get over your FOMO of knowing what's happening. Never miss what matters to you!
